ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Q.
Right arrow Articles by Ding, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Q.
Right arrow Articles by Ding, Y.
Annals of Clinical & Laboratory Science 34:87-93 (2004)
© 2004 Association of Clinical Scientists

The Optimal Hepatocyte Density for a Hollow-Fiber Bioartificial Liver

Qingxiang Xu, Xitai Sun, Yudong Qiu, Heyuan Zhang and Yitao Ding
Hepatobiliary Surgery Department, Affiliated Drum Tower Hospital of Medical College, Nanjing University, Nanjing, Peoples Republic of China

Address correspondence to Qingxiang Xu, M.D., Hepatobiliary Surgical Department, Affiliated Drum Tower Hospital of Nanjing University Medical College, Zhongshan Road 321, Nanjing, PR China 210008; tel 86 25 3304616 11601; fax: 86 25 3317016; e-mail: xqx008{at}hotmail.com.

A bioartificial liver (BAL) based on viable porcine hepatocytes can serve as a bridge to liver transplantation in patients with acute liver failure (ALF). To support liver functions, an adequate mass of hepatocytes is needed, which depends upon the cell density in the BAL device. This study evaluated the optimal density of hepatocytes within BAL devices that were constructed by perfusing porcine hepatocyte suspensions mixed with cytodex-3 into polysulfon hollow-fibers. The BAL devices were prepared with 6 different cell densities. The mass of hepatocytes in each device was evaluated for (a) cell viability, (b) ability to degrade diazepam, (c) ability to synthesize urea, (d) incorporation of [3H]-leucine into protein, (e) glucose-6-phosphatase activity, (f) total RNA content, and (g) p53 gene expression. Hepatocyte viability was about 90% in each device. With increasing hepatocyte density, the diazepam concentration in the medium decreased from 9.26±0.96 mg/L at 1 x 105 cells/ml to a minimum of 5.25±1.02 mg/L at 5 x106 cells/ml and thereafter remained at low levels. Urea production and [3H]-leucine incorporation into protein increased progressively until the cell density reached 5 x 106/ml and thereafter remained at high levels. Glucose-6-phosphatase activity and total RNA content stayed at high levels until the cell density reached 5 x 106/ml and then progressively decreased. p53 gene expression differed from the other parameters, since it increased only when the cell density reached 5 x 107/ml. In conclusion, the density of 5 x 106 cells/ml is a critical inflection point for most of the functional parameters, although p53 gene expression is not elevated at this cell density. These findings suggest that 5 x 106 cells/ml is the optimal hepatocyte density in the hollow-fiber BAL device.

Keywords: bioartificial liver, acute liver failure, hepatocytes







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association of Clinical Scientists.